Back
Dianthus Therapeutics, Inc. Stock Predictions
Meet America's Newest $1B Unicorn
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at
Buy
75
DNTH
Dianthus Therapeutics, Inc.
Last Price:
$44.76
Seasonality Move:
32.46%
7 Day Trial
ALL ACCESS PASS
$
7
The Next Gold Rush
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available atDianthus Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Dianthus Therapeutics, Inc. has on average historically risen by 27.8% based on the past 7 years of stock performance.
-
Dianthus Therapeutics, Inc. has risen higher in 4 of those 7 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.14%
-
Is Dianthus Therapeutics, Inc. Stock Undervalued?The current Dianthus Therapeutics, Inc. [DNTH] share price is $44.86. The Score for DNTH is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
-
DNTH is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
Will Dianthus Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Dianthus Therapeutics, Inc. has on average historically risen by 27.8% based on the past 7 years of stock performance.
Dianthus Therapeutics, Inc. Stock Rating
Buy
75
Dianthus Therapeutics, Inc. (DNTH)
is a Buy
Is Dianthus Therapeutics, Inc. overpriced?
-
Dianthus Therapeutics, Inc. has risen higher in 4 of those 7 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.14%
Dianthus Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
dianthustx.com
52-Week Data
52-Week High:
46.22
52-Week Low:
13.37
Prediction Charts
Market Cap:
1.9B
Price in USD:
44.86
Volume:
1.7M
Beta:
1.99
Technical Analysis
SMA50:
40.39
SMA100:
36.77
SMA200:
28.05
52-Wk Change:
94.7%
Stock Predictions
-
Is Dianthus Therapeutics, Inc. stock public?Yes, Dianthus Therapeutics, Inc. is a publicly traded company.
-
What is the Dianthus Therapeutics, Inc. stock quote today?The Dianthus Therapeutics, Inc. stock price is 44.86 USD today.
-
How to buy Dianthus Therapeutics, Inc. stock online?You can buy Dianthus Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-22 | 42.50 | 43.77 | 44.00 | 42.11 |
| Dec-23 | 43.39 | 42.61 | 43.72 | 42.02 |
| Dec-24 | 42.89 | 43.15 | 43.23 | 42.40 |
| Dec-26 | 43.40 | 41.83 | 43.40 | 41.46 |
| Dec-29 | 41.86 | 41.62 | 42.93 | 41.33 |
| Dec-30 | 41.43 | 40.96 | 41.96 | 40.79 |
| Dec-31 | 40.99 | 41.21 | 41.66 | 40.95 |
| Jan-5 | 39.65 | 36.89 | 40.77 | 36.21 |
| Jan-6 | 36.51 | 36.20 | 36.87 | 35.84 |
| Jan-7 | 36.56 | 38.09 | 39.23 | 36.56 |
| Jan-8 | 38.02 | 38.12 | 38.65 | 36.77 |
| Jan-9 | 38.44 | 38.19 | 39.34 | 37.96 |
| Jan-12 | 38.30 | 39.12 | 39.80 | 36.71 |
| Jan-13 | 39.11 | 44.86 | 46.22 | 38.95 |
Dianthus Therapeutics, Inc. Earnings
Dianthus Therapeutics, Inc. Earnings Report: Per Share Dianthus Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Dianthus Therapeutics, Inc. Forecast Revenue Growth
Dianthus Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Dianthus Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.14 per share, and a decrease next year of $0.43 per share.
* Dianthus Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.